Patient dosimetry of 177Lu-PSMA I&T in metastatic prostate cancer treatment: the experience in Thailand.

Kotchakorn ChatachotShuichi ShiratoriTawatchai ChaiwatanaratKitiwat Khamwan

Published in: Annals of nuclear medicine (2021)

Dosimetry results in this study suggested that 177Lu-PSMA I&T treatment with higher activities and more cycles is possible without the risk of damaging normal organs in prostate cancer patients.

Keyphrases

prostate cancer
pet ct
radical prostatectomy
computed tomography
replacement therapy